Innate Pharma SA ADR (IPHA.O)

+ 收藏

资产负债表(Innate Pharma SA ADR)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2024年年报2024年中报2023年年报2023年中报
截止日期 2025-06-302024-12-312024-06-302023-12-312023-06-30
报表类型 合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231
原始币种 欧元欧元欧元欧元欧元
上市前/上市后 上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见71,414,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见55,566,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见17,475,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见144,455,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见7,262,000.00
 无形资产(元) --会员可见会员可见903,000.00
 预付款项及其他长期应收款非流动(元) 会员可见会员可见会员可见会员可见880,000.00
 递延所得税资产非流动(元) --会员可见会员可见9,674,000.00
 长期投资(元) 会员可见会员可见会员可见会员可见35,790,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见86,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见54,594,000.00
总资产(元) 会员可见会员可见会员可见会员可见199,049,000.00
流动负债:
 应付账款及票据(元) 会员可见会员可见会员可见会员可见18,991,000.00
 递延收入流动(元) 会员可见会员可见会员可见会员可见5,050,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见会员可见13,626,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见37,667,000.00
非流动负债:
 递延收入非流动(元) 会员可见会员可见会员可见会员可见5,974,000.00
 递延所得税负债非流动(元) --会员可见会员可见9,674,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见87,869,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见103,518,000.00
总负债(元) 会员可见会员可见会员可见会员可见141,185,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见4,027,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见381,371,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-330,315,000.00
 其他储备(元) 会员可见会员可见会员可见会员可见1,064,000.00
 归属于母公司股东权益其他项目(元) 会员可见会员可见会员可见会员可见1,718,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见57,863,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见57,863,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见199,048,000.00
公告日期 2025-09-172025-04-302024-09-122024-04-042023-09-14
会计准则 国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则
审计意见
核数师

前瞻产业研究院